Fisetin (20 μM, 48 h) markedly reduced 5′ CpG promoter methylations and reactivated several TSGs, including TP53, PTEN (PINK1), RASSF1, RUNX1, APC2, DAPK1, FOXO3, PERP, RARβ, SOCS1, SOX1, CDH13, TIMP2, TIMP3, WIF1, and VHL, many of which are silenced in cervical cancer (Figure 5a). The gene discussed is PINK1; the disease is cervical carcinoma.